Myeloma Minute: Skeptical of Cancer News?


Time to Add a Healthy Dose of Skepticism to a Diet of Cancer News?

In his blog this week, IMF Chairman Dr. Brian Durie examines the Cancer Moonshot project’s recently announced “10 recommendations to Fight Cancer” alongside a thought-provoking article published in Nature that asks whether or not so-called “precision oncology” is an illusion. The concept of precision oncology is simple, writes Dr. Durie, “find the mutation and shut it down. Bingo—problem solved. But not so fast…” To read Dr. Durie’s blog, click HERE.


Register Now for the Upcoming Living Well with Myeloma Teleconference

Don’t miss the next teleconference in the Living Well with Myeloma series next Thursday, September 22, 2016 at 4 PM PT / 7 PM ET. IMF Medical Liaison Dr. Rafat Abonour (Indiana University – Simon Cancer Center) and Dr. Edward Stadtmauer (University of Pennsylvania) will present “CAR T-Cell Therapy: What Myeloma Patients & Caregivers Need to Know.” Chimeric antigen receptor (CAR) T-cells are part of a class of cancer therapies known as immunotherapies. With CAR T-cell therapy, a patient’s T-cells are harvested and genetically reengineered to become better able to recognize and attack myeloma. The altered T-cells are then reinfused into the body with the hope of fighting the disease. Pre-registration for this free teleconference is highly recommended here.  Watch the replay HERE.



Patient & Family Seminar in the Czech Republic Is a Success!

Last week, the 2016 Czech Republic Patient & Family Seminar took place in the city of Lazne Belhorad with 130 patients participating in educational sessions with Drs. Roman Hájek, Vladimir Maisnar, Ludek Pour, Jakub Radocha, Jan Straub, and Petr Hylena. Popular presentations included discussions of patient suitability for transplant, management of neuropathy, side effects, and new drugs for myeloma. The leadership and membership of both the Czech Myeloma Group and the Slovak Myeloma Society patient groups were well-represented, and the meeting’s success was due in part to the long-standing collaboration between these two organizations.


Dance and Dine to Support the IMF

In November 2013, Matt Blennau was diagnosed with multiple myeloma at the age of 36. An active coach, husband, and father, Matt underwent a clinical trial, multiple rounds of chemotherapy, and a stem cell transplant. Today he continues to live with multiple myeloma, while also enduring rounds of chemo every other week. Inspired by his fortitude, his sister Debbie reached out to the IMF to organize “A Mission for Matt,” a dinner and dance. This FUNdraiser takes place from 7 p.m. to 11 p.m. on Saturday, October 1, 2016 at the Knights of Columbus Council at 186 Jericho Turnpike in Mineola, New York. Register or donate HERE.


We Would Like to Thank Our Sponsors: Takeda Oncology, Celgene, Amgen, and Bristol-Myers Squibb

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.